protease-resistant aggregates (amyloid fibers). Modeling prion propagation, the lag time preceding aggregation can be eliminated by the addition of a small amount of premade fibers or cell lysate from a [PSI ϩ ] culture (8, 9 4 and 7; however, see ref. 10) .
As predicted by the prion model, [PSI ϩ ] can appear spontaneously, and the frequency of its appearance can be enhanced Ͼ1,000-fold by overproduction of Sup35 or its prion domain (11, 12) . However, the presence of an epigenetic element named [PIN ϩ ], for [PSI ϩ ] inducibility, facilitates both the spontaneous appearance of [PSI ϩ ] or its induction with excess Sup35 (13) . Although [PIN ϩ ] is required for efficient [PSI ϩ ] appearance, it is not needed for [PSI ϩ ] propagation (14) . Recently, by using the strains in which [PIN ϩ ] was first characterized, the Pin ϩ phenotype (i.e., the possibility of de novo formation of [PSI ϩ ]), was shown to be due to a prion form of Rnq1 (15), a previously described prion (16 ], or expression of any of 11 proteins from high-copy plasmids can also cause the Pin ϩ phenotype (15, 17) . Two of these proteins were previously known or proposed to be able to become prions themselves (Ure2 and New1). The other nine have Q-or Q͞N-rich domains similar to those present in Sup35 and other yeast prions.
Protein aggregation is a hallmark of many degenerative human diseases. For example, Huntington's and Machado-Joseph diseases are familial disorders caused by polyQ expansions in the huntingtin (Ht) and Machado-Joseph disease proteins, respectively, and are characterized by the accumulation of aggregates composed of these proteins in neurons (see ref. 18 ). In healthy individuals, the polyQ region of these proteins is generally composed of 12-40 Q's, when the number of Q's is greater than this the diseases occur with increased frequency, corresponding to the increase in polyQ region length. Amyloidogenic proteins not carrying Q-or Q͞N-rich domains have been linked to Parkinson's disease (PD), Alzheimer's disease (AD) and systemic amyloidoses (see refs. 19 and 20) , and recent data suggest that interactions of different amyloidogenic proteins play a role in PD and AD pathogenesis (21) .
We previously hypothesized that various heterogeneous prions and prion-like aggregates help initiate the de novo formation Abbreviations: Ht, huntingtin; PD, Parkinson's disease; CFP, cyan fluorescent protein; YFP, yellow fluorescent protein; TTR, transthyretin; TTRd, mutant D-strand-deleted TTR; ␣Syn, ␣-synuclein; Synph-1, synphilin-1; GuHCl, guanidine hydrochloride.
of [PSI ϩ
], and that the Q-or Q͞N-rich domains found in Sup35, as well as in heterologous aggregate-forming proteins, are likely to be important for epigenetic protein-based inheritance as well as for protein folding diseases (15) . Here, we study the effects of polyQ and non-polyQ aggregates on [PSI ϩ ] induction and the acceleration of Sup35 fiber formation by Q͞N-rich and non-Q͞N amyloids. Methods, which is published as supporting information on the PNAS web site). Unless specified, growth was at 30°C in media selective for plasmid maintenance.
Materials and Methods
Centromeric pNM-GFP plasmids, identical except for URA3 (22) , HIS3 (15), or LEU2 (this work) markers and made from pRS316, pRS413, and pRS415, respectively, carry a CUP1-driven fusion of amino acids 1-254 of Sup35 with GFP. Similar plasmids with LEU2 and HIS3 markers carrying a Rnq1-GFP fusion were made based on pRnq1-GFP, which was described (16) . Otherwise identical pRnq-CFP and pNM-YFP constructs were made by replacing GFP with appropriate cyan fluorescent protein (CFP) or yellow fluorescent protein (YFP) amplicons (see Supporting Materials and Methods for details on these and other vectors). The sequence of the RNQ1 ORF in all of the constructs is identical to that of WT Rnq1, except for a 3-aa N-terminal extension (MGS) and a 5-aa deletion (NNGNQN) at the extreme C terminus. 
Results

Facilitation of the de Novo Induction of [PSI ؉ ] by Aggregation-Prone
Alleles of Ht. To investigate the importance of Q-or Q͞N-rich sequences for initiating prion seeding, we tested whether con- structs carrying the first exon of Ht with an uninterrupted polyQ sequence of variable length could facilitate the de novo appearance of [PSI ϩ ]. When expressed in yeast, the constructs encompassing Ht exon 1 with an expanded polyQ region associated with early disease onset (Q53, Q72, and Q103) form cytoplasmic aggregates (and aggregation increases with the length of the polyQ tract, as well as with increased levels of expression), whereas WT Ht (Q25) remains soluble (24, 30) . Some constructs of Ht with expanded Q tracts are toxic (31, 32) ; however, we used a nontoxic version that retains Q-length-dependent aggregation (M. Duennwald, S. Jagadish, S. Willingham, S.L.L., and P. Muchowski (33) . ␣Syn plays a central role in PD, forming cytoplasmic inclusions called Lewy bodies, and is implicated in several other neurodegenerative disorders: the point mutation ␣SynA30P is associated with early onset of PD (34) . Synph-1, an ␣Syn-interacting protein (35) , is found in Lewy bodies in brains of patients with sporadic PD (36) .
Each protein, fused to a fluorescent tag to visualize aggregates, was constitutively expressed. TTR-WT, TTRd, and Synph-1 aggregates were easily detected, and their frequency and shape were not affected by the presence of [RNQ ϩ ] ( Fig.  2A) . Recently, ␣Syn-WT, but not ␣SynA30P, was found to aggregate in yeast (25) . Here, we found these aggregation properties to be independent of the presence of [ (Fig. 4 , which is published as supporting information on the PNAS web site). Furthermore, CFP-tagged TTR-WT or TTRd and NM-YFP exhibited frequent but not obligatory colocalization (Fig. 2B) . Thus, even amyloidogenic non-polyQ aggregates can sometimes colocalize with Sup35 aggregates. Fig. 1 were transiently grown on YPD plus 5 mM GuHCl and were then scored for retention of suppression on media without GuHCl. Because some suppressors cause a transient change of color in GuHCl (53), cells were considered to have been [PSI ϩ ] only if they remained red following growth on GuHCl. Note that occasional [PSI ϩ ] colonies found among the rare Ade ϩ colonies in cultures carrying the empty vector, Q25, or Q47 constructs (see Fig. 1 
Stimulation of Conversion of NM to Amyloid Fibers by Heterologous
Amyloids. We tested whether preparations of Rnq1 fibers would stimulate conversion of NM into amyloid in vitro. The formation of such amyloids closely mimics the propagation of the prion and has recently been shown to provide bona fide seed that transforms cells to the prion state (37, 38) . Fiber formation was monitored by fluorescence emission of thioflavin T (Fig. 3 A and  B) and confirmed by atomic force microscopy (G. J. Sawicki, S.M.U., and S.L.L., unpublished work). Conversion of soluble NM into amyloid occurred when Rnq1 preformed sonicated fibers were added at a value equal to 10% mol͞mol, and the rate of NM conversion increased as the ratio of Rnq1 to NM increased (Fig. 3A) . Clearly, Rnq1 aggregates stimulated conversion of NM into amyloid, although much less efficiently than NM stimulated its own conversion.
On the contrary, TTR-WT and ␣Syn amyloids did not seed NM conversion even when added at 50% mol͞mol ratio (Fig. 3C ). This result in vitro is in agreement with the inability of TTR and ␣Syn aggregates to facilitate [PSI ϩ ] induction in vivo. However, bovine pancreas insulin and human Ig light-chain amyloids, which lack Q͞N-rich regions, did stimulate NM conversion (Fig. 3D) , and the degree of stimulation decreased when less amyloid was added. Also, sonication of these amyloids before their addition to soluble NM further increased the efficiency of conversion, as expected, if the amyloid fibers were seeding NM at their ends. The ability to stimulate NM conversion was specific to the amyloid form: 50% soluble insulin failed to stimulate NM conversion (Fig. 3D) . Moreover, other proteins that were ␤-sheet-rich but not in an aggregated form (RNase A, Fig. 3D ), or that were nonspecifically aggregated (lysozyme, Fig. 3D ), did not stimulate NM conversion. Thus, neither ␤-sheet structure nor aggregation alone was sufficient to augment conversion, nor does the lack of a Q͞N-rich domain necessarily preclude it.
Discussion
A seeding model was proposed to explain how heterologous prions, e.g., [RNQ ϩ ], facilitate the de novo appearance of [PSI ϩ ]. According to this model, a heterologous preexisting protein in the prion conformation templates the conversion of Sup35 into its prion form. The alternative titration model postulates that preexisting heterologous prions or prion-like aggregates capture and inactivate an inhibitor that prevents conversion of Sup35 into a prion (15, 17) . The observations in this paper do not disprove the titration model, but they strongly support the seeding model.
[PSI ϩ ] aggregates appear to be amyloid (39) , and the behavior of a short N-terminal Sup35 peptide in vitro suggests that Sup35 amyloid is composed of densely packed parallel ␤-sheets (40) that are likely similar to the parallel ␤-sheet structure proposed for ataxin-3, which has a polyQ domain (41) . The Q-, N-, and Q͞N-rich domains from two different proteins might form ''polar zippers'' (42), enabling heterologous protein aggregates to seed [PSI ϩ ]. Amyloidogenic sequences that are not Q-or N-rich may not be as likely to interact with the Sup35 prion domain. Indeed, we found that overexpression of the aggregation-prone, polyQ-containing domain of Ht supplied Pin ϩ activity, whereas several amyloid forming proteins that were not Q-or N-rich did not.
The seeding model postulates a direct interaction between newly forming prions and preexisting heterologous prion or prion-like aggregates. Reported antagonistic interactions between prions also suggest a direct interaction (43, 44) . Indeed, binding of a Q͞N-rich domain to the growth tip of a heterologous prion seed that could occasionally lead to the formation of a novel prion might also block the propagation of the heterologous seed. One argument against the seeding model is that (45) . Although the colocalization of Rnq1 and newly forming Sup35 aggregates supports the seeding model, our results suggest that once seeding has occurred Rnq1 and Sup35 do not coassemble, but, rather, each protein has a much greater capacity to convert itself than to cross convert. Also, colocalization without extensive coaggregation was reported (46) for an aggregation-prone rhodopsin mutant and a construct with an expanded polyQ stretch.
We also observed occasional colocalization of [PSI ϩ ] and TTR aggregates. Because TTR aggregates did not promote [PSI ϩ ] formation, colocalization of existing aggregates does not necessarily mean that these proteins can promote prion formation. More likely, it reflects the tendency of certain types of aggregates to colocalize in common sites (47) . (9, 51) .
Two other non-Q͞N-rich amyloids tested, insulin and Ig, weakly augmented Sup35 fiber formation in vitro, perhaps through other ␤-strand interactions. It is unknown whether any non Q͞N rich amyloids can support [PSI ϩ ] conversion in vivo, nor whether the assay used here would be sensitive enough to detect it.
Recently, aggregation-prone proteins have been detected together in disease-associated aggregates and have been shown to facilitate each other's polymerization into amyloid lesions (52) . A link between the conformational changes associated with Q-length-dependent Huntington's disease and yeast prions was established by demonstrating enhanced aggregation and toxicity of polyQ-expanded proteins in the presence of [RNQ ϩ ] or [NU ϩ ] (17, 31) and a possible interaction of Rnq1 and polyQ (32) . Our results further support the concept that common protein-folding mechanisms underlie processes as diverse as epigenetic proteinbased inheritance and neurodegenerative diseases.
